Dynavax Technologies, a company in the biomedical and genetics industry, underperformed the market index on August 8, 2025.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Dynavax Technologies, a company in the biomedical and genetics industry, underperformed the market index on August 8, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Dynavax Technologies (United States)
company in Berkeley, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksDynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates Dynavax Technologies (DVAX) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per